StonvexLoading…
StonvexStonvexStonvexCore line items from HBAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.56B | $1.47B | $1.40B | $1.32B |
Operating Income | $2.69B | $2.40B | $2.38B | $2.76B |
Net Income | $2.21B | $1.94B | $1.95B | $2.24B |
EPS (Diluted) | $1.39 | $1.22 | $1.24 | $1.45 |
Total Assets | $225.11B | $204.23B | $189.37B | $182.91B |
Total Liabilities | $200.73B | $184.45B | $169.97B | $165.14B |
Cash & Equivalents | $13.49B | $12.85B | $10.13B | $6.70B |
Free Cash Flow OCF − CapEx | $2.21B | $1.69B | $2.52B | $3.81B |
Shares Outstanding | 1.57B | 1.45B | 1.45B | 1.44B |